General, Emergency and Transplant Surgery Department, Ospedale di Circolo e Fondazione Macchi, University of Insubria, Varese, Italy.
Urology Department, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
Biomed Res Int. 2019 Mar 25;2019:7343182. doi: 10.1155/2019/7343182. eCollection 2019.
The choice of modality for renal replacement therapy in patients with ADPKD varies, often based on patient choice, physician-related factors, and resource availability. For a long time peritoneal dialysis (PD) was considered as relative contraindication due to the possible limited intraperitoneal space. In recent years, some studies suggested it is a valid option also in patients with ADPKD to be considered as a first line treatment in potentially fit patients. Diuresis volume lowering and potential permanent damage of peritoneal integrity, both leading to a necessary switch to haemodialysis, are the two most important dangers after nephrectomy, especially if bilateral, in PD patients. We performed a retrospective analysis of patient underwent native polycystic kidney nephrectomy in order to state the possibility to recover peritoneal dialysis after surgery.
在 ADPKD 患者中，肾替代治疗方式的选择因患者选择、与医生相关的因素和资源可用性而异。长期以来，由于可能存在有限的腹腔空间，腹膜透析（PD）被认为是相对禁忌症。近年来，一些研究表明，PD 也是 ADPKD 患者的一种有效选择，可被视为潜在适合患者的一线治疗方法。在 PD 患者中，肾切除术后，两个最重要的危险是利尿量降低和潜在的腹膜完整性永久性损害，这两者均导致需要转为血液透析。我们对接受原发性多囊肾病肾切除术的患者进行了回顾性分析，以确定手术后恢复腹膜透析的可能性。
